Zentek Stock (NASDAQ:ZTEK)
Previous Close
$0.92
52W Range
$0.80 - $1.59
50D Avg
$0.98
200D Avg
$1.13
Market Cap
$92.28M
Avg Vol (3M)
$33.66K
Beta
0.84
Div Yield
-
ZTEK Company Profile
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
ZTEK Performance
Peer Comparison
| Ticker | Company |
|---|---|
| NEPH | Nephros, Inc. |
| MMSI | Merit Medical Systems, Inc. |
| COO | The Cooper Companies, Inc. |
| KRMD | KORU Medical Systems, Inc. |
| AKYA | Akoya Biosciences, Inc. |
| HOLX | Hologic, Inc. |
| ATRI | Atrion Corporation |
| NVST | Envista Holdings Corporation |
| POCI | Precision Optics Corporation, Inc. |
| ANGO | AngioDynamics, Inc. |
| LMAT | LeMaitre Vascular, Inc. |
| HAE | Haemonetics Corporation |
| ICUI | ICU Medical, Inc. |
| PDEX | Pro-Dex, Inc. |